Literature DB >> 10814045

Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093.

J Kohno1, Y Koguchi, M Nishio, K Nakao, M Kuroda, R Shimizu, T Ohnuki, S Komatsubara.   

Abstract

Four novel proteasome inhibitors, TMC-95A-D (1-4) have been isolated from the fermentation broth of Apiospora montagnei Sacc. TC 1093, isolated from a soil sample. All of the molecular formulas of 1-4 were established as C(33)H(38)N(6)O(10) by high-resolution FAB-MS. Their planar structures were determined on the basis of extensive analyses of 1D and 2D NMR, and degradation studies. Compounds 1-4 have the same planar structures to each other, and are unique highly modified cyclic peptides containing L-tyrosine, L-aspargine, highly oxidized L-tryptophan, (Z)-1-propenylamine, and 3-methyl-2-oxopentanoic acid units. The absolute configuration at C-11 and C-36 of 1-4 was determined based on chiral TLC and HPLC analyses of their chemical degradation products. The ROESY analysis along with (1)H-(1)H coupling constants clarified the absolute stereochemistry at C-6, -7, -8, and -14 of the cyclic moieties. These studies revealed the relationships of 1-4 to be diastereomers at C-7 and C-36.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814045     DOI: 10.1021/jo991375+

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  23 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  A concise, total synthesis of the TMC-95A/B proteasome inhibitors.

Authors:  Brian K Albrecht; Robert M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-26       Impact factor: 11.205

3.  α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

Authors:  Martina Bazzaro; Ravi K Anchoori; Mohana Krishna R Mudiam; Olga Issaenko; Srinivas Kumar; Balasubramanyam Karanam; Zhenhua Lin; Rachel Isaksson Vogel; Riccardo Gavioli; Federica Destro; Valeria Ferretti; Richard B S Roden; Saeed R Khan
Journal:  J Med Chem       Date:  2010-12-27       Impact factor: 7.446

4.  Asymmetric total synthesis and absolute stereochemistry of the neuroactive marine macrolide palmyrolide A.

Authors:  Rodolfo Tello-Aburto; Emily M Johnson; Cheyenne K Valdez; William A Maio
Journal:  Org Lett       Date:  2012-04-04       Impact factor: 6.005

5.  A Pd(0)-mediated indole (macro)cyclization reaction.

Authors:  Steven P Breazzano; Yam B Poudel; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-01-17       Impact factor: 15.419

6.  Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.

Authors:  Sevil Ozcan; Aslamuzzaman Kazi; Frank Marsilio; Bin Fang; Wayne C Guida; John Koomen; Harshani R Lawrence; Saïd M Sebti
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

7.  Highly enantioselective catalytic benzoyloxylation of 3-aryloxindoles using chiral VAPOL calcium phosphate.

Authors:  Zuhui Zhang; Wenhua Zheng; Jon C Antilla
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-22       Impact factor: 15.336

8.  Enantioselective allylation, crotylation, and reverse prenylation of substituted isatins: iridium-catalyzed C-C bond-forming transfer hydrogenation.

Authors:  Junji Itoh; Soo Bong Han; Michael J Krische
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  Total synthesis of TMC-95A and -B via a new reaction leading to Z-enamides. Some preliminary findings as to SAR.

Authors:  Songnian Lin; Zhi-Qiang Yang; Benjamin H B Kwok; Michael Koldobskiy; Craig M Crews; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2004-05-26       Impact factor: 15.419

10.  Development of Proteasome Inhibitors as Therapeutic Drugs.

Authors:  Samuel Troy Pellom; Anil Shanker
Journal:  J Clin Cell Immunol       Date:  2012-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.